Table 3.
Pathology | Response | Probiotic/Prebiotic | References |
---|---|---|---|
Crohn’s | ↓ IFN-γ, IL-12 | F. prausnitzii | [160] |
↑ IL-10 | Fructo-oligasaccharides | [167] | |
Ulcerative colitis | ↓ IL-1β, TNF-α, IFN-γ, IL-12 | L. plantarum 299v | [168] |
LGG | [169] | ||
↑ IL-10 | LGG | [169] | |
↓ β-defensins, TNF-α, IL-1, CRP | B. longum/Synergy 1 | [170] | |
↓ CRP | B. longum/psyllium | [171] | |
↓ adherence of B. vulgatas | LGG | [172] | |
↓ expression of tight junction proteins | VSL#3 | [172] | |
↓ tissue inflammation | VSL#3 | [173] | |
↑ no. γδ IEL ↓ no. γδ T-cells in lamina propria ↑ no. T-regs |
L. acidophilus + B. longum |
[87] | |
Reshape microbiota composition | VSL#3 | [174] | |
Colorectal Cancer | ↓ aberrant crypt formation ↓ cecal pH |
Bifidobacteria+ Lactobacilli + Inulin+ Oligofructose |
[175] |
↑ SCFA production ↓ IL-2 and iNOS |
Bifidobacteria+ Lactobacilli + Inulin + Oligofructose |
[176] | |
Colorectal Cancer | ↓ H2O2
↓ tissue inflammation ↑ catalase activity |
L. lactis | [177] |
↓ IL-2 and iNOS | B. lactis | [176] | |
L. rhamnosus | [178] | ||
↑ angiostatin ↑ no. CD4+ T-cells ↑ IL-17 and TNF-α |
VSL#3 | [179] | |
↓ CXCR4 mRNA expression ↓ MHC-class 1 ↓ tumour growth ↑ CT-26 cancer cell apoptosis |
L. acidophilus | [180] | |
Allergy | ↓ IL-4 and IL-5 | L. plantarum | [122] |
↑ IL-12 and IFN-γ | L. lactis | [181] | |
L. plantarum | [128] | ||
↓ IL-5, IL-4 and IL-13 | B. breve + oligosaccharide | [182] | |
↑ no. CD4+CD25+Foxp3+ T-regs | AhR ligand (TCDD) | [89] | |
↓ IL-12 ↔ no. T-regs |
B. breve + oligosaccharide | [183] | |
↑ no. bifidobacteria colonies ↓ no. Clostridium colonies ↓ faecal pH ↔ IgE ↔ levels of acetic acid |
B. breve + oligosaccharide | [184] | |
Coeliac | ↑ no. CD4+ T-cells ↑ IFN-γ |
L. casei | [185] |
↑ transepithelial resistance | B. lactis | [186] | |
↑ IL-12 and IFN-γ | Shigella CBD8 | [187] | |
↑ TNF-α |
B. bifidum
L. paracasei L. fermentum |
[187] [188] |
Overview of studies documenting the role of probiotic strains, prebiotics and synbiotic formulations and their effects on Crohn’s disease, Ulcerative colitis, colorectal cancer, allergy and coeliac’s disease. All studies are human studies detailing potential modulation of a variety of disease markers and immunological functional readouts. Arrows indicate decreases (↓), increases (↑) or no change (↔).